Personal information

Other IDs

Scopus Author ID: 6505627808

Activities

Collapse all

Employment (2)

The University of Texas MD Anderson Cancer Center: Houston, Texas, US

2011-10-20 to present | Clinical Pharmacy Specialist (Pharmacy Clinical Programs)
Employment
Source: Self-asserted source
Jitesh Kawedia

St. Jude Children's Research Hospital: Memphis, TN, US

2008-09-15 to 2011-10-15 | Fellow (Pharmaceutical Sciences)
Employment
Source: Self-asserted source
Jitesh Kawedia

Education and qualifications (5)

Texas State Board of Pharmacy: Austin, TX, US

2011-12-08 to present | RPh (Pharmacy)
Qualification
Source: Self-asserted source
Jitesh Kawedia

Tennessee State Board of Pharmacy: Nashville, TN, US

2010-02-11 to present | RPh (Pharmacy)
Qualification
Source: Self-asserted source
Jitesh Kawedia

University of Cincinnati: Cincinnati, OH, US

2002-09-01 to 2007-08-15 | PhD (Molecular Genetics, Biochemistry and Microbiology)
Education
Source: Self-asserted source
Jitesh Kawedia

University of Mumbai: Mumbai, MH, IN

1997-09-15 to 1999-09-15 | MS (Bioprocess Technology)
Education
Source: Self-asserted source
Jitesh Kawedia

University of Mumbai: Mumbai, MH, IN

1993-06-15 to 1997-05-15 | BS (Pharmacy)
Education
Source: Self-asserted source
Jitesh Kawedia

Works (50 of 64)

Items per page:
Page 1 of 2

Data from Targeting the mTOR Pathway for the Prevention of ER-Negative Breast Cancer

2023-04-03 | Preprint
DOI: 10.1158/1940-6207.c.6547163
Contributors: Abhijit Mazumdar; William M. Tahaney; Jamal L. Hill; Yun Zhang; Sumankalai Ramachandran; Jitesh Kawedia; Jing Qian; Alejandro Contreras; Michelle I. Savage; Lana A. Vornik et al.
Source: check_circle
Crossref

Data from Targeting the mTOR Pathway for the Prevention of ER-Negative Breast Cancer

2023-04-03 | Preprint
DOI: 10.1158/1940-6207.c.6547163.v1
Contributors: Abhijit Mazumdar; William M. Tahaney; Jamal L. Hill; Yun Zhang; Sumankalai Ramachandran; Jitesh Kawedia; Jing Qian; Alejandro Contreras; Michelle I. Savage; Lana A. Vornik et al.
Source: check_circle
Crossref

Supplementary Data from Targeting the mTOR Pathway for the Prevention of ER-Negative Breast Cancer

2023-04-03 | Preprint
DOI: 10.1158/1940-6207.22533608.v1
Contributors: Abhijit Mazumdar; William M. Tahaney; Jamal L. Hill; Yun Zhang; Sumankalai Ramachandran; Jitesh Kawedia; Jing Qian; Alejandro Contreras; Michelle I. Savage; Lana A. Vornik et al.
Source: check_circle
Crossref

Supplementary Data from Targeting the mTOR Pathway for the Prevention of ER-Negative Breast Cancer

2023-04-03 | Preprint
DOI: 10.1158/1940-6207.22533608
Contributors: Abhijit Mazumdar; William M. Tahaney; Jamal L. Hill; Yun Zhang; Sumankalai Ramachandran; Jitesh Kawedia; Jing Qian; Alejandro Contreras; Michelle I. Savage; Lana A. Vornik et al.
Source: check_circle
Crossref

Supplementary Figure from Targeting the mTOR Pathway for the Prevention of ER-Negative Breast Cancer

2023-04-03 | Preprint
DOI: 10.1158/1940-6207.22533605
Contributors: Abhijit Mazumdar; William M. Tahaney; Jamal L. Hill; Yun Zhang; Sumankalai Ramachandran; Jitesh Kawedia; Jing Qian; Alejandro Contreras; Michelle I. Savage; Lana A. Vornik et al.
Source: check_circle
Crossref

Supplementary Figure from Targeting the mTOR Pathway for the Prevention of ER-Negative Breast Cancer

2023-04-03 | Preprint
DOI: 10.1158/1940-6207.22533605.v1
Contributors: Abhijit Mazumdar; William M. Tahaney; Jamal L. Hill; Yun Zhang; Sumankalai Ramachandran; Jitesh Kawedia; Jing Qian; Alejandro Contreras; Michelle I. Savage; Lana A. Vornik et al.
Source: check_circle
Crossref

Phase I Trial of Definitive Concurrent Chemoradiotherapy and Trametinib for KRAS-Mutated Non-Small Cell Lung Cancer

Cancer Treatment and Research Communications
2022 | Journal article
DOI: 10.1016/j.ctarc.2022.100514
Part of ISSN: 2468-2942
Contributors: Steven H Lin; Heather Y Lin; Vivek Verma; Meng Xu-Welliver; Peter F Thall; Luyang Yao; Peter Y Kim; Dan S Gombos; Jitesh D Kawedia; Ritsuko Komaki et al.
Source: Self-asserted source
Jitesh Kawedia via Crossref Metadata Search

Targeting the mTOR Pathway for the Prevention of ER-Negative Breast Cancer

Cancer Prevention Research
2022-12-01 | Journal article
DOI: 10.1158/1940-6207.CAPR-22-0106
Contributors: Abhijit Mazumdar; William M. Tahaney; Jamal L. Hill; Yun Zhang; Sumankalai Ramachandran; Jitesh Kawedia; Jing Qian; Alejandro Contreras; Michelle I. Savage; Lana A. Vornik et al.
Source: check_circle
Crossref

Vorinostat Combined with Busulfan, Fludarabine, and Clofarabine Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Leukemia: Long-Term Study Outcomes

Transplantation and Cellular Therapy
2022-08 | Journal article
DOI: 10.1016/j.jtct.2022.05.021
Contributors: Gheath Alatrash; Chantal Saberian; Roland Bassett; Peter F. Thall; Celina Ledesma; Yoshimi Lu; May Daher; Benigno C. Valdez; Jitesh Kawedia; Uday Popat et al.
Source: check_circle
Crossref

A Prospective Phase I/II Trial to Jointly Optimize the Administration Schedule and Dose of Melphalan for Injection (Evomela) As a Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation in Newly Diagnosed Multiple Myeloma

Blood
2021-11-05 | Journal article
DOI: 10.1182/blood-2021-149807
Part of ISSN: 0006-4971
Contributors: Qaiser Bashir; Peter F. Thall; Dawen Sui; Jeremy L. Ramdial; Samer A. Srour; Rohtesh S. Mehta; Uday R. Popat; Yago Nieto; Neeraj Saini; Partow Kebriaei et al.
Source: Self-asserted source
Jitesh Kawedia via Crossref Metadata Search

Optimizing Myeloablative Fractionated Busulfan, Fludarabine and Thiotepa Regimen: Results of Two Parallel Cohorts in a Phase 2 Prospective Clinical Trial

Blood
2021-11-05 | Journal article
DOI: 10.1182/blood-2021-146655
Part of ISSN: 0006-4971
Contributors: Uday R. Popat; Rohtesh S. Mehta; Roland Bassett; Amin M. Alousi; Gheath Alatrash; Qaiser Bashir; Chitra Hosing; Jin S. Im; Partow Kebriaei; Jitesh D. Kawedia et al.
Source: Self-asserted source
Jitesh Kawedia via Crossref Metadata Search

Post-Transplant Cyclophosphamide Versus Tacrolimus and Methotrexate to Prevent Graft-Versus-Host Disease in Recipients of Matched Donor Transplantation: Comparison of Sequential Cohorts in a Prospective Trial

Blood
2021-11-05 | Journal article
DOI: 10.1182/blood-2021-146245
Part of ISSN: 0006-4971
Contributors: Uday R. Popat; Rohtesh S. Mehta; Roland Bassett; Amin M. Alousi; Gheath Alatrash; Qaiser Bashir; Chitra Hosing; Jin S. Im; Partow Kebriaei; Jitesh D. Kawedia et al.
Source: Self-asserted source
Jitesh Kawedia via Crossref Metadata Search

Asparaginase-Associated Pancreatitis in Pediatric Patients with Acute Lymphoblastic Leukemia: Current Perspectives.

Paediatric drugs
2021-08-05 | Journal article
DOI: 10.1007/s40272-021-00463-1
PMID: 34351604
Source: Self-asserted source
Jitesh Kawedia
grade
Preferred source (of 3)‎

Myeloablative Fractionated Busulfan With Fludarabine in Older Patients: Long Term Disease-Specific Outcomes of a Prospective Phase II Clinical Trial.

Transplantation and cellular therapy
2021-07-28 | Journal article
DOI: 10.1016/j.jtct.2021.07.021
PMID: 34329753
Source: Self-asserted source
Jitesh Kawedia

Chemical Degradation of Intravenous Chemotherapy Agents and Opioids by a Novel Instrument

Hospital Pharmacy
2020 | Journal article
DOI: 10.1177/0018578720931456
EID:

2-s2.0-85086089306

Part of ISSN: 19451253 00185787
Contributors: Macdonell, M.; Kawedia, J.D.; Zhang, Y.P.; Roux, R.; Myers, A.L.
Source: Self-asserted source
Jitesh Kawedia via Scopus - Elsevier
grade
Preferred source (of 2)‎

Letter to the Editor Regarding “Harmonization of Busulfan Plasma Exposure Unit (BPEU): A Community-Initiated Consensus Statement”

Biology of Blood and Marrow Transplantation
2020 | Journal article
DOI: 10.1016/j.bbmt.2020.03.022
EID:

2-s2.0-85086917524

Part of ISSN: 15236536 10838791
Contributors: Kawedia, J.D.; Handy, V.W.; Shigle, T.L.; Gulbis, A.M.; Nieto, Y.; Andersson, B.S.
Source: Self-asserted source
Jitesh Kawedia via Scopus - Elsevier
grade
Preferred source (of 2)‎

A Randomized Study of Pretransplant Conditioning Therapy for AML/MDS with Fludarabine ± Clofarabine and Once Daily IV Busulfan with Allogeneic Hematopoietic Transplantation for AML and MDS

Blood
2020-11-05 | Journal article
DOI: 10.1182/blood-2020-142680
Part of ISSN: 0006-4971
Contributors: Borje S. Andersson; Peter Thall; Benigno C. Valdez; Junsheng Ma; Julianne Chen; Sairah Ahmed; Amin M. Alousi; Qaiser Bashir; Stefan O. Ciurea; Alison Gulbis et al.
Source: Self-asserted source
Jitesh Kawedia via Crossref Metadata Search

Myeloablative Fractionated Busulfan with Fludarabine in Older Patients: Long Term Outcomes of Prospective Phase II Clinical Trial

Blood
2020-11-05 | Journal article
DOI: 10.1182/blood-2020-139325
Part of ISSN: 0006-4971
Contributors: Rohtesh S. Mehta; Roland Bassett; Julianne Chen; Benigno C. Valdez; Jitesh Kawedia; Amin M. Alousi; Gheath Alatrash; Qaiser Bashir; Stefan Ciurea; Chitra Hosing et al.
Source: Self-asserted source
Jitesh Kawedia via Crossref Metadata Search

Trial in Progress: A Prospective Phase I/II Trial to Jointly Optimize the Administration Schedule(s) and Dose(s) of Melphalan for Injection (Evomela) As a Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation in Newly Diagnosed Multiple Myeloma

Blood
2020-11-05 | Journal article
DOI: 10.1182/blood-2020-139853
Part of ISSN: 0006-4971
Contributors: Qaiser Bashir; Peter F Thall; Dawen Sui; Cristina Knape; Jitesh Kawedia; Muzaffar H. Qazilbash
Source: Self-asserted source
Jitesh Kawedia via Crossref Metadata Search

A phase I trial of aerosol gemcitabine for the treatment of patients with solid tumors and lung metastases.

Journal of Clinical Oncology
2020-05 | Journal article
DOI: 10.1200/jco.2020.38.15_suppl.tps3645
Part of ISSN: 0732-183X
Contributors: Nancy Beatriz Gordon; Eugenie Kleinerman; Ajay Sheshadri; David Blanco; Sireesha Yedururi; Ajaykumar Morani; Jonathan Benjamin Gill; Douglas James Harrison; Cynthia E. Herzog; J Andrew Livingston et al.
Source: Self-asserted source
Jitesh Kawedia via Crossref Metadata Search

A rare case of methotrexate and primaquine co-administration in a mantle cell lymphoma patient

Journal of Clinical Pharmacy and Therapeutics
2019 | Journal article
DOI: 10.1111/jcpt.12849
EID:

2-s2.0-85066078511

Part of ISSN: 13652710 02694727
Contributors: Myers, A.L.; Kawedia, J.D.; Nader, A.; Westin, J.R.; Shank, B.R.
Source: Self-asserted source
Jitesh Kawedia via Scopus - Elsevier
grade
Preferred source (of 2)‎

Conditioning with busulfan plus melphalan versus melphalan alone before autologous haemopoietic cell transplantation for multiple myeloma: an open-label, randomised, phase 3 trial

The Lancet Haematology
2019 | Journal article
DOI: 10.1016/S2352-3026(19)30023-7
EID:

2-s2.0-85064587550

Part of ISSN: 23523026
Contributors: Bashir, Q.; Thall, P.F.; Milton, D.R.; Fox, P.S.; Kawedia, J.D.; Kebriaei, P.; Shah, N.; Patel, K.; Andersson, B.S.; Nieto, Y.L. et al.
Source: Self-asserted source
Jitesh Kawedia via Scopus - Elsevier
grade
Preferred source (of 3)‎

Pharmacokinetics: Unique challenges in blood monitoring for oncology nurses

Clinical Journal of Oncology Nursing
2019 | Journal article
DOI: 10.1188/19.CJON.191-196
EID:

2-s2.0-85063257654

Part of ISSN: 1538067X 10921095
Contributors: Kawedia, J.D.; Kalariya, N.; Gulbis, A.M.; Andersson, B.S.; Myers, A.L.
Source: Self-asserted source
Jitesh Kawedia via Scopus - Elsevier
grade
Preferred source (of 2)‎

A Randomized Study of Fludarabine-Clofarabine Vs Fludarabine Alone Combined with Busulfan and Allogeneic Hematopoietic Transplantation for AML and MDS

Blood
2019-11 | Journal article
DOI: 10.1182/blood-2019-124921
Part of ISSN: 0006-4971
Contributors: Richard E. Champlin; Uday Popat; Betul Oran; Stefan O. Ciurea; Partow Kebriaei; Amin M. Alousi; Gheath Alatrash; Qaiser Bashir; Issa F. Khouri; Chitra Hosing et al.
Source: Self-asserted source
Jitesh Kawedia via Crossref Metadata Search

Stability of Captisol-Enabled Melphalan (Evomela) in 0.9% Sodium Chloride Solution in IV Bags and Glass Vials at Room Temperature and Refrigeration

Biology of Blood and Marrow Transplantation
2019-03 | Journal article
DOI: 10.1016/j.bbmt.2018.12.363
Part of ISSN: 1083-8791
Contributors: Jitesh D. Kawedia; Sumankalai Ramachandran; Alison M. Gulbis; Mark Titus; Qaiser Bashir; Muzaffar H. Qazilbash; Richard E. Champlin; Stefan O. Ciurea
Source: Self-asserted source
Jitesh Kawedia via Crossref Metadata Search

Aerosol Gemcitabine after Amputation Inhibits Osteosarcoma Lung Metastases but Not Wound Healing

Sarcoma
2018 | Journal article
DOI: 10.1155/2018/3143096
EID:

2-s2.0-85041851410

Part of ISSN: 13691643 1357714X
Contributors: Kleinerman, E.S.; Yu, L.; Dao, J.; Hayes-Jordan, A.A.; Lindsey, B.; Kawedia, J.D.; Stewart, J.; Gordon, N.
Source: Self-asserted source
Jitesh Kawedia via Scopus - Elsevier
grade
Preferred source (of 2)‎

Fludarabine with a higher versus lower dose of myeloablative timed-sequential busulfan in older patients and patients with comorbidities: an open-label, non-stratified, randomised phase 2 trial

The Lancet Haematology
2018 | Journal article
DOI: 10.1016/S2352-3026(18)30156-X
EID:

2-s2.0-85055625224

Part of ISSN: 23523026
Contributors: Popat, U.R.; Mehta, R.S.; Bassett, R.; Chen, J.; Valdez, B.C.; Kawedia, J.; Ahmed, S.; Alousi, A.M.; Anderlini, P.; Al-Atrash, G. et al.
Source: Self-asserted source
Jitesh Kawedia via Scopus - Elsevier
grade
Preferred source (of 3)‎

Clarifying busulfan metabolism and drug interactions to support new therapeutic drug monitoring strategies: a comprehensive review

Expert Opinion on Drug Metabolism and Toxicology
2017 | Journal article
DOI: 10.1080/17425255.2017.1360277
EID:

2-s2.0-85028850431

Part of ISSN: 17447607 17425255
Contributors: Myers, A.L.; Kawedia, J.D.; Champlin, R.E.; Kramer, M.A.; Nieto, Y.; Ghose, R.; Andersson, B.S.
Source: Self-asserted source
Jitesh Kawedia via Scopus - Elsevier
grade
Preferred source (of 2)‎

Fludarabine with pharmacokinetically guided IV busulfan is superior to fixed-dose delivery in pretransplant conditioning of AML/MDS patients

Bone Marrow Transplantation
2017 | Journal article
DOI: 10.1038/bmt.2016.322
EID:

2-s2.0-85006365203

Part of ISSN: 14765365 02683369
Contributors: Andersson, B.S.; Thall, P.F.; Valdez, B.C.; Milton, D.R.; Al-Atrash, G.; Chen, J.; Gulbis, A.; Chu, D.; Martinez, C.; Parmar, S. et al.
Source: Self-asserted source
Jitesh Kawedia via Scopus - Elsevier
grade
Preferred source (of 2)‎

Solubilization and Stability of Mitomycin C Solutions Prepared for Intravesical Administration

Drugs in R and D
2017 | Journal article
DOI: 10.1007/s40268-017-0183-y
EID:

2-s2.0-85018961217

Part of ISSN: 11796901 11745886
Contributors: Myers, A.L.; Zhang, Y.-P.; Kawedia, J.D.; Zhou, X.; Sobocinski, S.M.; Metcalfe, M.J.; Kramer, M.A.; Dinney, C.P.N.; Kamat, A.M.
Source: Self-asserted source
Jitesh Kawedia via Scopus - Elsevier
grade
Preferred source (of 2)‎

Asparaginase potentiates glucocorticoid-induced osteonecrosis in a mouse model

PLoS ONE
2016 | Journal article
DOI: 10.1371/journal.pone.0151433
EID:

2-s2.0-84962591337

Part of ISSN: 19326203
Contributors: Liu, C.; Janke, L.J.; Kawedia, J.D.; Ramsey, L.B.; Cai, X.; Mattano, L.A.; Boyd, K.L.; Funk, A.J.; Relling, M.V.
Source: Self-asserted source
Jitesh Kawedia via Scopus - Elsevier
grade
Preferred source (of 2)‎

Physical and chemical stability of proflavine contrast agent solutions for early detection of oral cancer

Journal of Oncology Pharmacy Practice
2016 | Journal article
DOI: 10.1177/1078155214546564
EID:

2-s2.0-84960874004

Part of ISSN: 1477092X 10781552
Contributors: Kawedia, J.D.; Zhang, Y.-P.; Myers, A.L.; Richards-Kortum, R.R.; Kramer, M.A.; Gillenwater, A.M.; Culotta, K.S.
Source: Self-asserted source
Jitesh Kawedia via Scopus - Elsevier
grade
Preferred source (of 2)‎

Stability of tacrolimus injection diluted in 0.9% sodium chloride injection and stored in Excel bags

American Journal of Health-System Pharmacy
2016 | Journal article
DOI: 10.2146/ajhp150677
EID:

2-s2.0-85002142096

Part of ISSN: 15352900 10792082
Contributors: Myers, A.L.; Zhang, Y.; Kawedia, J.D.; Shank, B.R.; Deaver, M.A.; Kramer, M.A.
Source: Self-asserted source
Jitesh Kawedia via Scopus - Elsevier
grade
Preferred source (of 2)‎

Stability study of carboplatin infusion solutions in 0.9% sodium chloride in polyvinyl chloride bags

Journal of Oncology Pharmacy Practice
2016 | Journal article
DOI: 10.1177/1078155214546016
EID:

2-s2.0-84960896650

Part of ISSN: 1477092X 10781552
Contributors: Myers, A.L.; Zhang, Y.-P.; Kawedia, J.D.; Trinh, V.A.; Tran, H.; Smith, J.A.; Kramer, M.A.
Source: Self-asserted source
Jitesh Kawedia via Scopus - Elsevier
grade
Preferred source (of 2)‎

In Contrast to Phenytoin, Levetiracetam Does Not Increase Busulfan Clearance When Given As Anti-Seizure Prophylaxis

Biology of Blood and Marrow Transplantation
2016-03 | Journal article
DOI: 10.1016/j.bbmt.2015.11.806
Part of ISSN: 1083-8791
Contributors: Jitesh D. Kawedia; Alan L. Myers; Mark A. Kramer; Alison M. Gulbis; Richard E. Champlin; Borje S. Andersson; Uday R. Popat
Source: Self-asserted source
Jitesh Kawedia via Crossref Metadata Search

Myeloablative Timed Sequential Busulfan is Safe and Appears Promising in Older Patients with AML/MDS

Biology of Blood and Marrow Transplantation
2016-03 | Journal article
DOI: 10.1016/j.bbmt.2015.11.302
Part of ISSN: 1083-8791
Contributors: Uday R. Popat; Genevieve Lyons; Roland Bassett; Julianne Chen; Ben C. Valdez; Jitesh D. Kawedia; Sairah Ahmed; Amin M. Alousi; Paolo Anderlini; Qaiser Bashier et al.
Source: Self-asserted source
Jitesh Kawedia via Crossref Metadata Search

Myeloablative Timed Sequential Busulfan Is Safe in Patients with Relapsed or High-Risk Multiple Myeloma

Biology of Blood and Marrow Transplantation
2016-03 | Journal article
DOI: 10.1016/j.bbmt.2015.11.636
Part of ISSN: 1083-8791
Contributors: Muzaffar H. Qazilbash; Julianne Chen; Ben C. Valdez; Koji Sasaki; Jitesh D. Kawedia; Qaiser Bashir; Chitra Hosing; Partow Kebriaei; Yago Nieto; Nina Shah et al.
Source: Self-asserted source
Jitesh Kawedia via Crossref Metadata Search

A phase I/II study of the mTOR inhibitor everolimus in combination with hyperCVAD chemotherapy in patients with relapsed/refractory acute lymphoblastic leukemia

Clinical Cancer Research
2015 | Journal article
DOI: 10.1158/1078-0432.CCR-14-2888
EID:

2-s2.0-84942113290

Part of ISSN: 15573265 10780432
Contributors: Daver, N.; Boumber, Y.; Kantarjian, H.; Ravandi, F.; Cortes, J.; Rytting, M.E.; Kawedia, J.D.; Basnett, J.; Culotta, K.S.; Zeng, Z. et al.
Source: Self-asserted source
Jitesh Kawedia via Scopus - Elsevier
grade
Preferred source (of 3)‎

Myeloablative Timed Sequential Busulfan Is Safe in Patients With Relapsed or High-Risk Multiple Myeloma

Clinical Lymphoma Myeloma and Leukemia
2015-09 | Journal article
DOI: 10.1016/j.clml.2015.07.601
Part of ISSN: 2152-2650
Contributors: M.H. Qazilbash; J. Chen; B.C. Valdez; J. Kawedia; Q. Bashir; C.M. Hosing; P. Kebriaei; Y. Nieto; S. Parmar; N. Shah et al.
Source: Self-asserted source
Jitesh Kawedia via Crossref Metadata Search

Comparison of adult oncology phase 1 trials to pediatric oncology phase 1 trials of targeted therapies.

Journal of Clinical Oncology
2015-05 | Journal article
DOI: 10.1200/jco.2015.33.15_suppl.2581
Part of ISSN: 0732-183X
Contributors: Vivek Subbiah; Jitesh D Kawedia; Anthony Christensen; Kenneth R. Hess; Kayuri Patel; Elaine Wood; Ryan D Bitar; Najat C. Daw
Source: Self-asserted source
Jitesh Kawedia via Crossref Metadata Search

A phase I/II study combining erlotinib and dasatinib for non-small cell lung cancer

Oncologist
2014 | Journal article
DOI: 10.1634/theoncologist.2014-0228
EID:

2-s2.0-84929914778

Part of ISSN: 1549490X 10837159
Contributors: Gold, K.A.; Jack Lee, J.; Harun, N.; Tang, X.; Price, J.; Kawedia, J.D.; Tran, H.T.; Erasmus, J.J.; Blumenschein, G.R.; William, W.N. et al.
Source: Self-asserted source
Jitesh Kawedia via Scopus - Elsevier
grade
Preferred source (of 2)‎

Asparaginase in acute lymphoblastic leukemia

Clinical Lymphoma, Myeloma and Leukemia
2014 | Journal article
DOI: 10.1016/j.clml.2014.06.017
EID:

2-s2.0-84925970010

Part of ISSN: 21522669 21522650
Contributors: Kawedia, J.D.; Rytting, M.E.
Source: Self-asserted source
Jitesh Kawedia via Scopus - Elsevier
grade
Preferred source (of 2)‎

Myeloablative Timed Sequential Busulfan Is Safe in Older Patients

Blood
2014 | Journal article
DOI: 10.1182/blood.v124.21.3859.3859
Part of ISSN: 0006-4971
Contributors: Uday R. Popat; Patricia S Fox; Roland Bassett; Julianne Chen; Benigno C. Valdez; Jitesh Kawedia; Sairah Ahmed; Amin M. Alousi; Qaiser Bashir; Stefan O. Ciurea et al.
Source: Self-asserted source
Jitesh Kawedia via Crossref Metadata Search

Physical and chemical stability of high-dose ifosfamide and mesna for prolonged 14-day continuous infusion

Journal of Oncology Pharmacy Practice
2014 | Journal article
DOI: 10.1177/1078155213478284
EID:

2-s2.0-84892922731

Part of ISSN: 10781552 1477092X
Contributors: Zhang, Y.; Kawedia, J.D.; Myers, A.L.; McIntyre, C.M.; Anderson, P.M.; Kramer, M.A.; Culotta, K.S.
Source: Self-asserted source
Jitesh Kawedia via Scopus - Elsevier
grade
Preferred source (of 2)‎

Physical and chemical stability of reconstituted and diluted dexrazoxane infusion solutions

Journal of Oncology Pharmacy Practice
2014 | Journal article
DOI: 10.1177/1078155213480070
EID:

2-s2.0-84892946720

Part of ISSN: 10781552 1477092X
Contributors: Zhang, Y.-P.; Myers, A.L.; Trinh, V.A.; Kawedia, J.D.; Kramer, M.A.; Benjamin, R.S.; Tran, H.T.
Source: Self-asserted source
Jitesh Kawedia via Scopus - Elsevier
grade
Preferred source (of 2)‎

Pilot study to assess toxicity and pharmacokinetics of docetaxel in patients with metastatic breast cancer and impaired liver function secondary to hepatic metastases

Journal of Oncology Pharmacy Practice
2014 | Journal article
DOI: 10.1177/1078155213480536
EID:

2-s2.0-84898948465

Part of ISSN: 1477092X 10781552
Contributors: Eckmann, K.; Michaud, L.B.; Rivera, E.; Madden, T.L.; Esparza-Guerra, L.; Kawedia, J.; Booser, D.J.; Green, M.C.; Hortobagyi, G.N.; Valero, V.
Source: Self-asserted source
Jitesh Kawedia via Scopus - Elsevier
grade
Preferred source (of 2)‎

Abstract CT409: Dexamethasone (dex) and asparaginase increase triglycerides during acute lymphoblastic leukemia (ALL) therapy in children

Clinical Trials
2014-09 | Other
DOI: 10.1158/1538-7445.am2014-ct409
Contributors: Laura B. Ramsey; Katherine M. Robinson; Jitesh D. Kawedia; Wenjian Yang; Chengcheng Liu; John C. Panetta; Sima Jeha; Deepa Bhojwani; Monika L. Metzger; Cheng Cheng et al.
Source: Self-asserted source
Jitesh Kawedia via Crossref Metadata Search

Hypoxia and Hypoxia Mimetics Decrease Aquaporin 5 (AQP5) Expression through Both Hypoxia Inducible Factor-1α and Proteasome-Mediated Pathways

PLoS ONE
2013 | Journal article
DOI: 10.1371/journal.pone.0057541
EID:

2-s2.0-84874580236

Part of ISSN: 19326203
Contributors: Kawedia, J.D.; Yang, F.; Sartor, M.A.; Gozal, D.; Czyzyk-Krzeska, M.; Menon, A.G.
Source: Self-asserted source
Jitesh Kawedia via Scopus - Elsevier
grade
Preferred source (of 2)‎

Primary epiphyseal arteriopathy in a mouse model of steroid-induced osteonecrosis

American Journal of Pathology
2013 | Journal article
DOI: 10.1016/j.ajpath.2013.03.004
EID:

2-s2.0-84879345324

Part of ISSN: 00029440 15252191
Contributors: Janke, L.J.; Liu, C.; Vogel, P.; Kawedia, J.; Boyd, K.L.; Funk, A.J.; Relling, M.V.
Source: Self-asserted source
Jitesh Kawedia via Scopus - Elsevier
grade
Preferred source (of 2)‎

A Phase I/II Study Of Hyper-CVAD Plus Everolimus In Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

Blood
2013-11 | Journal article
DOI: 10.1182/blood.v122.21.3916.3916
Part of ISSN: 0006-4971
Contributors: Naval Daver; Hagop M. Kantarjian; Deborah A. Thomas; Michael E. Rytting; Farhad Ravandi; Nitin Jain; Jorge E. Cortes; Rebecca Garris; Mary Ann Richie; Marina Konopleva et al.
Source: Self-asserted source
Jitesh Kawedia via Crossref Metadata Search
Items per page:
Page 1 of 2

Peer review (6 reviews for 2 publications/grants)

Review activity for Advances in therapy. (1)
Review activity for Heliyon. (5)
How many people are using ORCID?